69 related articles for article (PubMed ID: 16030310)
21. [Effect of vascular endothelial growth factor on apoptosis and expression of Bcl-2 and Mcl-1 in acute leukemia cells].
Liao XL; Xie XT; Li BS; Li L; Yang LL
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Dec; 8(6):491-5. PubMed ID: 17178043
[TBL] [Abstract][Full Text] [Related]
22. No association of the NFKB1 insertion/deletion promoter polymorphism with survival in colorectal and renal cell carcinoma as well as disease progression in B-cell chronic lymphocytic leukemia.
Riemann K; Becker L; Struwe H; Nückel H; Dührsen U; Alakus H; Winde G; Neuhäuser M; Rübben H; Schmitz KJ; Wohlschlaeger J; Schmid KW; Siffert W
Pharmacogenet Genomics; 2006 Nov; 16(11):783-8. PubMed ID: 17047486
[TBL] [Abstract][Full Text] [Related]
23. Use of IGHJ and IGHD gene mutations in analysis of immunoglobulin sequences for the prognosis of chronic lymphocytic leukemia.
Lee CE; Jackson KJ; Sewell WA; Collins AM
Leuk Res; 2007 Sep; 31(9):1247-52. PubMed ID: 17169423
[TBL] [Abstract][Full Text] [Related]
24. The 9p24.3 breakpoint of a constitutional t(6;9)(p12;p24) in a patient with chronic lymphocytic leukemia maps close to the putative promoter region of the DMRT2 gene.
Rüssel J; Dutta U; Wand D; Schlote D; Hansmann I
Cytogenet Genome Res; 2009; 125(2):81-6. PubMed ID: 19729909
[TBL] [Abstract][Full Text] [Related]
25. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
Souwer Y; Chamuleau ME; van de Loosdrecht AA; Tolosa E; Jorritsma T; Muris JJ; Dinnissen-van Poppel MJ; Snel SN; van de Corput L; Ossenkoppele GJ; Meijer CJ; Neefjes JJ; Marieke van Ham S
Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431
[TBL] [Abstract][Full Text] [Related]
26. Analysis of 11q22-q23 deletion target genes in B-cell chronic lymphocytic leukaemia: evidence for a pathogenic role of NPAT, CUL5, and PPP2R1B.
Kalla C; Scheuermann MO; Kube I; Schlotter M; Mertens D; Döhner H; Stilgenbauer S; Lichter P
Eur J Cancer; 2007 May; 43(8):1328-35. PubMed ID: 17449237
[TBL] [Abstract][Full Text] [Related]
27. Differential DNA methylation of gene promoters in small B-cell lymphomas.
Guo J; Burger M; Nimmrich I; Maier S; Becker E; Genc B; Duff D; Rahmatpanah F; Chitma-Matsiga R; Shi H; Berlin K; Huang TH; Caldwell CW
Am J Clin Pathol; 2005 Sep; 124(3):430-9. PubMed ID: 16191512
[TBL] [Abstract][Full Text] [Related]
28. The three-substituted indolinone cyclin-dependent kinase 2 inhibitor 3-[1-(3H-imidazol-4-yl)-meth-(Z)-ylidene]-5-methoxy-1,3-dihydro-indol-2-one (SU9516) kills human leukemia cells via down-regulation of Mcl-1 through a transcriptional mechanism.
Gao N; Kramer L; Rahmani M; Dent P; Grant S
Mol Pharmacol; 2006 Aug; 70(2):645-55. PubMed ID: 16672643
[TBL] [Abstract][Full Text] [Related]
29. Determination of unknown genomic sequences without cloning.
Quivy JP; Becker PB
Methods Mol Biol; 2003; 226():373-84. PubMed ID: 12958524
[No Abstract] [Full Text] [Related]
30. Detection of somatic quantitative genetic alterations by multiplex polymerase chain reaction for the prediction of outcome in diffuse large B-cell lymphomas.
Jardin F; Ruminy P; Kerckaert JP; Parmentier F; Picquenot JM; Quief S; Villenet C; Buchonnet G; Tosi M; Frebourg T; Bastard C; Tilly H
Haematologica; 2008 Apr; 93(4):543-50. PubMed ID: 18287131
[TBL] [Abstract][Full Text] [Related]
31. The MDM2 -309 T/G promoter single nucleotide polymorphism does not alter disease characteristics in chronic lymphocytic leukemia.
Zenz T; Häbe S; Benner A; Kienle D; Döhner H; Stilgenbauer S
Haematologica; 2008 Jul; 93(7):1111-3. PubMed ID: 18508789
[No Abstract] [Full Text] [Related]
32. Combined PER2 and CRY1 expression predicts outcome in chronic lymphocytic leukemia.
Eisele L; Prinz R; Klein-Hitpass L; Nückel H; Lowinski K; Thomale J; Moeller LC; Dührsen U; Dürig J
Eur J Haematol; 2009 Oct; 83(4):320-7. PubMed ID: 19500131
[TBL] [Abstract][Full Text] [Related]
33. Mutagenicity of non-homologous end joining DNA repair in a resistant subset of human chronic lymphocytic leukaemia B cells.
Deriano L; Merle-Béral H; Guipaud O; Sabatier L; Delic J
Br J Haematol; 2006 Jun; 133(5):520-5. PubMed ID: 16681639
[TBL] [Abstract][Full Text] [Related]
34. [Relationship of interleukin-18 gene promoter polymorphisms with chronic hepatitis B in Chinese Han population].
Zhang PA; Wu JM; Li Y; Yang XS
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Oct; 22(5):528-32. PubMed ID: 16215941
[TBL] [Abstract][Full Text] [Related]
35. Epigenetics and chronic lymphocytic leukemia.
Yu MK
Am J Hematol; 2006 Nov; 81(11):864-9. PubMed ID: 16924647
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic and genetic analysis of the survivin promoter in acute myeloid leukemia.
Wagner M; Schmelz K; Dörken B; Tamm I
Leuk Res; 2008 Jul; 32(7):1054-60. PubMed ID: 18206228
[TBL] [Abstract][Full Text] [Related]
37. Human leucocyte antigen-C in B chronic lymphocytic leukaemia.
Montes-Ares O; Moya-Quiles MR; Montes-Casado M; Guerra-Pérez N; Campillo JA; González C; López-Bermejo A; Tamayo M; Majado MJ; Parrado A; Muro M; Marín L; Alvarez-López MR
Br J Haematol; 2006 Nov; 135(4):517-9. PubMed ID: 17054674
[TBL] [Abstract][Full Text] [Related]
38. MCL-1ES, a novel variant of MCL-1, associates with MCL-1L and induces mitochondrial cell death.
Kim JH; Sim SH; Ha HJ; Ko JJ; Lee K; Bae J
FEBS Lett; 2009 Sep; 583(17):2758-64. PubMed ID: 19683529
[TBL] [Abstract][Full Text] [Related]
39. Cyclic AMP delays neutrophil apoptosis via stabilization of Mcl-1.
Kato T; Kutsuna H; Oshitani N; Kitagawa S
FEBS Lett; 2006 Aug; 580(19):4582-6. PubMed ID: 16876795
[TBL] [Abstract][Full Text] [Related]
40. Chronic lymphocytic leukaemia and acute myeloid leukaemia are not associated with AKT1 pleckstrin homology domain (E17K) mutations.
Zenz T; Döhner K; Denzel T; Döhner H; Stilgenbauer S; Bullinger L
Br J Haematol; 2008 May; 141(5):742-3. PubMed ID: 18410456
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
